CR:DOI:597122a60ca1220bc34eb933860bd38f: Difference between revisions
From IDWiki
(Created page with "{{#scite: |reference=brown2013me |type=article-journal |title=Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection |author=Kev...") |
No edit summary |
||
| Line 11: | Line 11: | ||
|pages=2326-2332 |
|pages=2326-2332 |
||
|doi=10.1128/aac.02176-12 |
|doi=10.1128/aac.02176-12 |
||
|subject=Pharmacology (medical);Pharmacology;Infectious Diseases|+sep=; |
|||
|issn=0066-4804;1098-6596|+sep=; |
|issn=0066-4804;1098-6596|+sep=; |
||
|retrieved-from=https://dx.doi.org/ |
|retrieved-from=https://dx.doi.org/ |
||
|retrieved-on= |
|retrieved-on=2020-11-11 |
||
|@show=true |
|@show=true |
||
}} |
}} |
||
Latest revision as of 13:55, 11 November 2020
{{#scite:
|reference=brown2013me
|type=article-journal
|title=Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection
|author=Kevin A. Brown;Nagham Khanafer;Nick Daneman;David N. Fisman|+sep=;
|journal=Antimicrobial Agents and Chemotherapy
|publisher=American Society for Microbiology
|year=2013
|volume=57
|issue=5
|pages=2326-2332
|doi=10.1128/aac.02176-12
|subject=Pharmacology (medical);Pharmacology;Infectious Diseases|+sep=;
|issn=0066-4804;1098-6596|+sep=;
|retrieved-from=https://dx.doi.org/
|retrieved-on=2020-11-11
}}
